Alzheimer Disease Clinical Trials in Washington D.C., District of Columbia

3 studies are recruiting for alzheimer disease in Washington D.C., District of Columbia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

    This is a study to evaluate the efficacy, safety, and tolerability of BMS-986368, a FAAH/MAGL inhibitor, for the treatment of agitation in participants with Alzheimer's Disease.

    Stage
    Phase 2
    Ages
    55 to 90
    Site
    Georgetown University, Washington D.C., District of Columbia
    Locations
    78 in total
    Run by
    Celgene

    See if you can join NCT06808984 on ClinicalTrials.gov

  2. Late Onset Alzheimer's Disease

    The goal of this study is to is to focus on the genetic influences on Alzheimer's Disease (AD) risk. The investigators are looking for families and/or individuals (affected or unaffected) of any ethic background (African American, Caucasian, and Hispanics) with a family history of AD and willing to…

    Stage
    Not phased
    Ages
    55 and older
    Site
    University of Washington, Washington D.C., District of Columbia
    Locations
    12 in total
    Run by
    Columbia University

    See if you can join NCT05010603 on ClinicalTrials.gov

  3. DC Longitudinal Study on Aging and Specimen Bank

    The Georgetown University Memory Disorders Program, part of the Department of Neurology, is conducting pilot studies of the feasibility of various diagnostic tests for Alzheimer's disease, mild cognitive impairment and other neurodegenerative diseases. Further, this study is assessing longitudinal …

    Stage
    Not phased
    Ages
    45 and older
    Site
    Georgetown University Memory Disorders Program, Washington D.C., District of Columbia
    Run by
    Georgetown University

    See if you can join NCT03702907 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.